People · Operator

Marc Christopher Silver

Named in public records as an officer, director or promoter · active 2009–2009 · Hospitals and Physicians

1
Companies
1
Filings
$154K
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Genesys Cardiovascular Co-Management Company, LLCHospitals and PhysiciansPre-Seed$154K$4.4M2009
Operator network

Marc Christopher Silver at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Christopher Joseph Palazzolo · 3 companies · 1 sharedChristopher Josep…Elizabeth LeVan Aderholdt · 3 companies · 1 sharedElizabeth LeVan A…James Clayton Bonnette · 3 companies · 1 sharedJames Clayton Bon…Abdulfatah Abdelkarim Osman · 1 companies · 1 sharedAbdulfatah Abdelk…David Allan Brill · 1 companies · 1 sharedDavid Allan BrillDavid Robert Dobies · 1 companies · 1 sharedDavid Robert Dobi…Dennis Vincent DeSimone · 1 companies · 1 sharedDennis Vincent De…Jeffrey Edward Ledis · 1 companies · 1 sharedJeffrey Edward Le…Michael James Jule · 1 companies · 1 sharedMichael James JuleRussell William Becker · 1 companies · 1 sharedRussell William B…Genesys Cardiovascular Co-Management Company, LLC · $0.2M raisedGenesys Cardiovascula…Marc Christopher SilverMS
Marc Christopher Silver Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marc Christopher Silver on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Elizabeth LeVan Aderholdt13
Christopher Joseph Palazzolo13
James Clayton Bonnette13
David Allan Brill11
Michael James Jule11
David Robert Dobies11
Russell William Becker11
Abdulfatah Abdelkarim Osman11
Jeffrey Edward Ledis11
Dennis Vincent DeSimone11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.